Annemarie Koch

Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Antineoplastic therapy affects the in vitro phenotype and functionality of healthy human bone marrow-derived mesenchymal stromal cells.

Antineoplastic therapy affects the in vitro phenotype and functionality of healthy human bone marrow-derived mesenchymal stromal cells.

Journal: Archives of toxicology

Published: October 01, 2024

Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms.

Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms.

Journal: Cancers

Published: April 19, 2024

Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.

Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.

Journal: Blood advances

Published: September 12, 2023

Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.

Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.

Journal: Stem cells (Dayton, Ohio)

Published: November 12, 2020

Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.

Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.

Journal: Haematologica

Published: December 19, 2017

The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.

The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.

Journal: Current molecular medicine

Published: December 18, 2016

Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.

Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.

Journal: Cancer genomics & proteomics

Published: June 28, 2014

Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.

Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 29, 2014

HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma.

HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma.

Journal: Frontiers in oncology

Published: June 24, 2013

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: May 06, 2012

Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Journal: Asian journal of andrology

Published: February 28, 2012

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.

Journal: Urologic oncology

Published: December 20, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026